Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

buy

Vertex Pharmaceuticals Inc. buy StockNews.com

Vertex Pharmaceuticals Inc.

Start price

€366.75

/ 50%

Target price

27.12.24

Performance (%)

Price

Summary

This prediction is currently active. Since the start of the prediction for Vertex Pharmaceuticals Inc. the price has only changed by . This prediction currently runs until 27.12.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
Vertex Pharmaceuticals Inc.
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by StockNews_com for this prediction

In the thread Vertex Pharmaceuticals Inc. diskutieren

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.

Ratings data for VRTX provided by MarketBeat

0

Stopped prediction by StockNews_com for Vertex Pharmaceuticals Inc.

Vertex Pharmaceuticals Inc.

Start price

Target price

Perf. (%)

€370.05

20.04.25

50%

Vertex Pharmaceuticals Inc.

Start price

Target price

Perf. (%)

€371.25

13.04.25

50%

Vertex Pharmaceuticals Inc.

Start price

Target price

Perf. (%)

€389.10

30.03.25

50%

Vertex Pharmaceuticals Inc.

Start price

Target price

Perf. (%)

€378.25

13.03.25

50%

Vertex Pharmaceuticals Inc.

Start price

Target price

Perf. (%)

€394.00

12.01.25

50%

Vertex Pharmaceuticals Inc.

Start price

Target price

Perf. (%)

€341.50

21.10.24

50%

Vertex Pharmaceuticals Inc.

Start price

Target price

Perf. (%)

€352.65

14.10.24

50%

Vertex Pharmaceuticals Inc.

Start price

Target price

Perf. (%)

€323.70

30.08.24

50%